Scarica l'app Stockscreener
1.61
1.90%
0.03
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1.58
Aprire:
$1.58
Volume 24 ore:
358.62K
Relative Volume:
0.24
Capitalizzazione di mercato:
$110.61M
Reddito:
$832.00K
Utile/perdita netta:
$-135.12M
Rapporto P/E:
-0.2644
EPS:
-6.09
Flusso di cassa netto:
$-124.69M
1 W Prestazione:
-3.01%
1M Prestazione:
+0.63%
6M Prestazione:
-5.29%
1 anno Prestazione:
-24.41%
Intervallo 1D:
$1.57
$1.625
Intervallo di 1 settimana:
$1.555
$1.775
Portata 52W:
$1.30
$2.9789
Inovio Pharmaceuticals Inc Stock (INO) Company Profile
Nome
Inovio Pharmaceuticals Inc
Settore
Industria
Telefono
(858) 410-3134
Indirizzo
660 W. GERMANTOWN PIKE, PLYMOUTH MEETING, PA
Compare INO vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
INO
Inovio Pharmaceuticals Inc
|
1.61 | 108.55M | 832.00K | -135.12M | -124.69M | -6.09 |
|
VRTX
Vertex Pharmaceuticals Inc
|
491.47 | 117.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
803.17 | 82.85B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
821.96 | 51.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
314.40 | 40.75B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.07 | 38.33B | 4.98B | 69.60M | 525.67M | 0.5198 |
Inovio Pharmaceuticals Inc Stock (INO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-09 | Iniziato | Piper Sandler | Overweight |
| 2024-05-14 | Iniziato | Stephens | Overweight |
| 2024-01-25 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2022-11-09 | Downgrade | Maxim Group | Buy → Hold |
| 2022-11-01 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-07-19 | Ripresa | RBC Capital Mkts | Sector Perform |
| 2022-05-11 | Downgrade | Oppenheimer | Outperform → Perform |
| 2022-01-21 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2021-12-29 | Ripresa | Jefferies | Hold |
| 2021-09-10 | Downgrade | BofA Securities | Neutral → Underperform |
| 2021-06-24 | Iniziato | Jefferies | Hold |
| 2021-03-23 | Iniziato | BofA Securities | Neutral |
| 2021-02-12 | Iniziato | Oppenheimer | Outperform |
| 2020-11-17 | Downgrade | ROTH Capital | Neutral → Sell |
| 2020-11-10 | Aggiornamento | ROTH Capital | Sell → Neutral |
| 2020-09-28 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2020-09-28 | Aggiornamento | Maxim Group | Hold → Buy |
| 2020-07-01 | Downgrade | Maxim Group | Buy → Hold |
| 2020-07-01 | Downgrade | ROTH Capital | Neutral → Sell |
| 2020-06-29 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2020-06-26 | Downgrade | Stifel | Buy → Hold |
| 2020-05-21 | Iniziato | The Benchmark Company | Buy |
| 2020-04-30 | Downgrade | ROTH Capital | Buy → Neutral |
| 2020-03-13 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2020-03-13 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2019-12-19 | Iniziato | ROTH Capital | Buy |
| 2018-02-15 | Reiterato | Maxim Group | Buy |
| 2017-10-18 | Iniziato | RBC Capital Mkts | Outperform |
| 2017-09-06 | Iniziato | Citigroup | Buy |
| 2017-06-08 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2017-05-24 | Reiterato | Maxim Group | Buy |
| 2017-03-16 | Aggiornamento | Maxim Group | Hold → Buy |
| 2017-03-16 | Downgrade | Piper Jaffray | Overweight → Neutral |
Mostra tutto
Inovio Pharmaceuticals Inc Borsa (INO) Ultime notizie
ROSEN, A LEADING LAW FIRM, Encourages Inovio Pharmaceuticals Inc. Investors to Secure Counsel ... - Bluefield Daily Telegraph
INO SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) Investors ... - Bluefield Daily Telegraph
INO SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) Investors of Securities Class Action Deadline on April 7, 2026 - GlobeNewswire Inc.
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Inovio Pharmaceuticals Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionINO - ACCESS Newswire
DEADLINE ALERT for TCPC, ORCL, PSFE, and INO: The Law - GlobeNewswire
Forecast Cut: What’s next for Inovio Pharmaceuticals Inc. stockJuly 2025 Highlights & Daily Market Momentum Tracking - mfd.ru
2026-02-13 | INO SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Inovio Pharmaceuticals, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! | NDAQ:INO | Press Release - Stockhouse
ROSEN, LEADING INVESTOR COUNSEL, Encourages Inovio Pharmaceuticals Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionINO - ACCESS Newswire
INO DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) Investors of Securities Class Action Deadline on April 7, 2026 - ACCESS Newswire
Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc. and Certain OfficersINO - PR Newswire
Securities Fraud Investigation Into Inovio Pharmaceuticals, Inc. (INO) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm - marketscreener.com
Inovio Pharmaceuticals Under Investigation for Possible Securities Law Violations - Intellectia AI
FinancialContentInovio Pharmaceuticals, Inc. (INO) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation - FinancialContent
Securities Fraud Investigation Into Inovio Pharmaceuticals, Inc. (INO) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz - The AI Journal
Portnoy Law Firm Announces Class Action on Behalf of Inovio Pharmaceuticals, Inc. Investors - GlobeNewswire
Bronstein, Gewirtz & Grossman LLC Urges Inovio - GlobeNewswire
INOVIO to Participate in Multiple Scientific and Investor Conferences - Intellectia AI
Published on: 2026-02-12 16:56:02 - mfd.ru
INOVIO to Participate in Upcoming Scientific and Investor Conferences - Finviz
Inovio Pharmaceuticals Faces Class Action for Securities Fraud - Intellectia AI
DNA medicine developer INOVIO to present research at four events - Stock Titan
User - The Chronicle-Journal
Is Inovio Pharmaceuticals Inc. stock good for income investorsQuarterly Portfolio Review & Breakout Confirmation Alerts - mfd.ru
INOVIO CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. - GlobeNewswire
INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Business Wire
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Inovio - GlobeNewswire
INO SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) Investors of Securities Class Action Deadline on April 7, 2026 - The Malaysian Reserve
Will Inovio Pharmaceuticals Inc. stock see PE expansion2025 Investor Takeaways & Expert Curated Trade Setup Alerts - mfd.ru
INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, I - GuruFocus
IINO Stockholder Alert: Robbins LLP Reminds Investors of the Class Action Against Inovio Pharmaceuticals, Inc. - PR Newswire
INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit - InsideNoVa.com
INO INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Inovio Pharmaceuticals, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
DNA Nanotechnology Market Growth in Future Scope 2026-2033 - openPR.com
Rosen Law Firm Urges Inovio Pharmaceuticals, Inc. (NASDAQ: INO) Stockholders to Contact the Firm for - PharmiWeb.com
Rosen Law Firm Urges Inovio Paysafe Limited (NASDAQ: PSFE) Stockholders to Contact the Firm for Information About Their Rights - Business Wire
Inovio Pharmaceuticals Faces Class Action for Misleading Investors - Intellectia AI
Rosen Law Firm Urges Inovio Pharmaceuticals, Inc. (NASDAQ: INO) Stockholders to Contact the Firm for Information About Their Rights - Bluefield Daily Telegraph
Inovio Pharmaceuticals Faces Class Action Lawsuit Over Misleading Statements - Intellectia AI
Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the Inovio Pharmaceuti - PharmiWeb.com
Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the Inovio Pharmaceuticals, Inc. Class Action Lawsuit - Business Wire
Aug Sentiment: Is Inovio Pharmaceuticals Incs ROE strong enoughJuly 2025 Opening Moves & Risk Managed Investment Strategies - baoquankhu1.vn
INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of - GlobeNewswire
Stock Report: Is Inovio Pharmaceuticals Incs ROE strong enoughTrade Performance Summary & High Conviction Trade Alerts - baoquankhu1.vn
Risk Recap: Is Inovio Pharmaceuticals Inc a turnaround storyRate Cut & Daily Profit Focused Stock Screening - baoquankhu1.vn
Inovio Pharmaceuticals (INO) Price Target Increased by 12.14% to 8.73 - Nasdaq
Pomerantz LLP Investigates Inovio Securities Fraud Claims - Intellectia AI
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inovio Pharmaceuticals, Inc. - GlobeNewswire Inc.
Is Inovio Pharmaceuticals Inc a potential multi baggerEarnings Overview Report & Daily Stock Trend Watchlist - baoquankhu1.vn
Market Trends: What is the implied volatility of Match Group IncMarket Weekly Review & Comprehensive Market Scan Reports - baoquankhu1.vn
Guidance Update: Is Inovio Pharmaceuticals Inc a top pick in the sectorForecast Cut & AI Optimized Trading Strategy Guides - baoquankhu1.vn
Is Inovio Pharmaceuticals Inc.’s ROIC above industry average2025 Dividend Review & Free Long-Term Investment Growth Plans - mfd.ru
Inovio Pharmaceuticals Inc Azioni (INO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.12%
0.87%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):